Why the study?
Does the administration of Class I antiarrhythmic drugs alter the block cycle length required to interrupt sustained ventricular tachycardia?
Does the administration of Class I antiarrhythmic drugs alter the block cycle length required to interrupt sustained ventricular tachycardia?
Answers are grounded in this paper and cite their sources.
Using the block cycle length to interrupt sustained VT appears safe, and while Class I antiarrhythmics alter cycle lengths, the BCL/VTCL ratio remains above 60%, which may help avoid VT acceleration.
In nine patients who had inducible monomorphic sustained ventricular tachycardia (VT), rapid pacing was performed in 11 episodes of morphologically distinct VT at progressively shorter cycle lengths and VT was interrupted at a critical cycle length. The VT interrupting critical cycle length was defined as the block cycle length (BCL) and the effect of Class I antiarrhythmic drugs were examined. Both the VT cycle length (VTCL) and the BCL were prolonged after administration of either drug. The overall mean ratio of the BCL to the VTCL was unchanged after procainamide administration, but increased after the use of mexiletine. The ratio, however, varied in individual VTs and the BCL after treatment with Class I antiarrhythmic drugs could not be predicted from the ratio baseline value, although the ratio was always > 60% and the hazard of VT acceleration might be avoided if the BCL is used.
No takes yet. Share an insight, caveat, or question.
Ohira et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: